TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q4 2014. The put-call ratio across all filers is 3.53 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $386,000 | -33.0% | 21,116 | -15.5% | 0.00% | -33.3% |
| Q2 2014 | $576,000 | +4.3% | 25,000 | +9.6% | 0.00% | +50.0% |
| Q1 2014 | $552,000 | -68.7% | 22,800 | -66.5% | 0.00% | -77.8% |
| Q4 2013 | $1,765,000 | +441.4% | 68,000 | +353.3% | 0.01% | +350.0% |
| Q3 2013 | $326,000 | +38.1% | 15,000 | +7.1% | 0.00% | +100.0% |
| Q2 2013 | $236,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 739,669 | $13,514,000 | 6.33% |
| ACK Asset Management | 749,867 | $13,700,000 | 4.92% |
| CASTLEROCK ASSET MANAGEMENT INC | 26,751 | $489,000 | 4.12% |
| GOLDMAN CAPITAL MANAGEMENT INC | 309,297 | $5,651,000 | 2.83% |
| Paradice Investment Management LLC | 348,686 | $6,370,000 | 1.66% |
| Park West Asset Management LLC | 600,770 | $10,976,000 | 1.62% |
| Adirondack Research & Management Inc. | 220,638 | $4,031,000 | 1.50% |
| RK Capital | 375,043 | $6,852,000 | 1.40% |
| KEANE CAPITAL MANAGEMENT INC | 70,000 | $1,279,000 | 1.23% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 953,618 | $17,423,000 | 1.08% |